Vol 1 (September 30, 2025): Breast Communications

Editorial Commentary 
Caution against overinterpretation: a critical appraisal of artificial intelligence performance in interval breast cancer detection
Muharrem Oner, Kefah Mokbel
Breast Communications  
2025;
1:
5  
(30 September 2025) 
PDF Full Text (101) Peer Review File COI Form Open Access Get Permission
Study Protocol 
Neoadjuvant radiotherapy followed by chemotherapy combined with toripalimab immunotherapy in local advanced HR-positive, HER2-negative breast cancer: protocol for a phase II, single-arm, multicenter clinical study
Anran Pi, Di Zhang, Senxiang Yan, Qiuying Tang, Minya Yao, Luyan Chen, Shuqian Wang, Peifen Fu
Breast Communications  
2025;
1:
4  
(30 September 2025) 
PDF Full Text (107) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Case Report 
A metastatic breast cancer patient with twice HER2 status changes and BRCA2 secondary mutations: a case report
Yingyun Li, Jiayi Wu, Heqing Yuan, Lu Gao, Yiyuan Liu, Xiying Shao, Xiaojia Wang
Breast Communications  
2025;
1:
3  
(30 September 2025) 
PDF Full Text (94) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Brief Report 
A brief report on the significance of clustered microcysts in breast ultrasound of postmenopausal women, a retrospective cohort study
Afsaneh Alikhassi, Mia Skarpathiotakis, Hemi Dua, Belinda Curpen
Breast Communications  
2025;
1:
2  
(30 September 2025) 
PDF Full Text (89) Peer Review File COI Form Open Access Get Permission
Editorial 
The launch of Breast Communications (BC): advancing the communication of breast disease
Xiaojia Wang
Breast Communications  
2025;
1:
1  
(30 September 2025) 
PDF Full Text (40) COI Form Open Access Get Permission